Support: 888-992-3836 Home NewsWire Subscriptions

New Post Public Reply Private Reply Replies (1) Message Board
Garya
369
Support: 888-992-3836
Home
NewsWire
Subscriptions
Settings
Logout
InvestorsHub Logo
Search iHub
Mailbox 1
Favorites
Level 2

Here's a threat I received regarding JP!

Private Message
| |
Icon for StocksGoneWild
StocksGoneWild
Friday, June 17, 2022 11:53:11 AM

Gman111, I see you pretty much have abandoned the TOMDF board and spend most of your time here now on the MONI board. I'm about to teach you an important lesson. It's glaringly obvious that you are a low IQ stupid newbie to the OTC, and TOMDF was probably your first OTC trade, wasn't it? Your smooth wrinkle free brain probably also believes that the dumbfuck JP that you have dedicated your life to chasing around the internet is responsible for your problems, don't you? Your dumb ass actually believes that his worthless posts have an affect on your stock, don't you? Just like you think that your worthless shitposts on the MONI board have any affect on us. Well, I've decided that I will be teaching you and the other worthless TOMDF goons that have let your lives be consumed by that retard JP. I'm going to show you the difference between what retards like you & JP and someone who actually knows how to do proper research and make a convincing argument can do. I've been looking into your TOMDF pretty deeply and have found some quite disturbing information that I think TODMF shareholders are really going to appreciate, and since you and your gay buddies have let yourselves be consumed by that retard JP, and have dedicated your lives to punishing ALL MONI shareholders for what he's done, I'm going to show you newbie boomer fucks how to crash a stock. Every time I see one of your posts it just confirms that what I am going to do needs to be done. You freaks are not going to like it, and at this point, you might as well just keep carrying on with your retarded little games because there is nothing that will stop me from doing what I think needs to be done, and when I'm finished, I will make sure to be very clear about who motivated me to do it, and why, so I hope you're having a really good time, but I assure you, next week will not be fun for you. You brought this on yourself Gman111, enjoy your your long weekend worm. I'll see you freaks next week.
| |
In Reply To: this message on the 'Moon Equity Holdings Corp.' board
Icon for Gman111
Gman111
06/17/2022 11:28:47 AM

SELL SELL SELL!

© Copyright 2022

Follow InvestorsHub on Twitter! @investors_hub Like InvestorsHub on Facebook! See the latest blog posts from ADVFN on Medium!
About Us
Terms of Service
Privacy Policy
Advertise With Us
Data Accreditations
Disclaimer in
FAQ
Handbook
Q&A Forum
Contact Us
Corporate Solutions
Educational Channel
Stock Market 101
Investor Help Forum
iHub NewsWire
Get InvestorsHub on the iOS App Store
Get InvestorsHub on the Google Play Store

Todos Med Ltd. (TOMDF) Stock Research Links

TOMDF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 21

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 14

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

National Power Mobilizes Storm Response Teams for Hurricane

Updated Category News Views 119

National Power's Preparedness for Hurricane Milton As Hurricane Milton approaches, National Power has actively mobilized its dedicated teams to ensure mission-critical operations are not disrupted. With a strong focus on readiness, the company is prepared to deliver essential power and infrastructure support to vital services such as broadband and emergency facilities...

Continue Reading
Edible Garden Reports Significant Revenue Growth in CPG Sector

Updated Category News Views 138

Edible Garden Achieves 9% Revenue Growth Edible Garden AG Incorporated (NASDAQ: EDBL) has reported an encouraging 9% increase in revenue, marking a significant milestone for the company in the competitive consumer packaged goods (CPG) sector. The growth comes as Edible Garden diversifies its product offerings and expands its retail partnerships, positioning itself firmly...

Continue Reading
Sapiens International Announces Impressive Dividend Payouts

Updated Category News Views 304

Sapiens International Declares Substantial Cash Dividend Sapiens International Corporation N.V. (NASDAQ: SPNS), a distinguished leader in providing software solutions for the insurance industry, has unveiled a notable cash dividend distribution following their financial achievements. The board of directors has sanctioned a cash dividend of $0.30 per share, culminating in...

Continue Reading
Cybernet’s G22 Medical PC Revolutionizes Endoscopy at DDW 2025

Updated Category News Views 253

Cybernet’s Groundbreaking Medical Panel PC at DDW 2025 During the recent Digestive Disease Week (DDW) 2025 conference, the spotlight was on revolutionary advancements in endoscopic technology. A significant highlight was the display of the Cybermed G22, a state-of-the-art 22-inch medical panel PC. This cutting-edge device is integral to Fujifilm's next-generation...

Continue Reading
CVS Health's Strategic Moves Boost Medicare Margins and Market Share

Updated Category News Views 96

CVS Health's Strategic Upsurge in the Pharmacy Sector CVS Health Inc (NYSE: CVS) has recently come under the positive spotlight as Barclays improves its outlook on the company. The upgrade stems from more favorable predictions concerning Pharmacy & Consumer Wellness (PCW) estimates. Interestingly, despite facing macroeconomic challenges affecting the retail pharmacy...

Continue Reading